Emerging Growth Drivers in the Controlled Release Drug Delivery Market Landscape: Controlled-Release Drug Delivery Market Surges As Chronic Diseases Become Global Health Priority
Discover trends, market shifts, and competitive outlooks for the controlled release drug delivery industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Fast Is The Controlled Release Drug Delivery Market Expected to Grow Between 2025 And 2029?
The market size for controlled release drug delivery has experienced swift expansion in prior years. The market value is set to increase from $65.44 billion in 2024 to $73.01 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.6%. This significant growth during the historic period can be credited to the development of innovative drug delivery systems, the inception of polymer-based formulations, the implementation of microencapsulation techniques, the advent of transdermal delivery, regulatory consent, and standardization processes.
In the coming years, the controlled release drug delivery market is predicted to experience significant expansion. The market is projected to reach $119.41 billion in 2029 with a compound annual growth rate (CAGR) of 13.1%. This expected growth in the forecast period is due to several factors such as the shift towards personalized medicine, the integration of technology to enhance patient comfort, the broadening scope of biologics and biosimilars, market growth in emerging regions, and advances in polymer science. The forecast period will be characterized by major trends including the use of biodegradable and biocompatible materials, advancements in nanotechnology, personalized medicine and targeted therapies, development in implantable devices, and innovative encapsulation methods.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp
Which Primay Drivers Are Accelerating Growth in the Controlled Release Drug Delivery Market?
The growing incidence of long-term ailments is anticipated to drive the controlled release drug delivery market’s expansion. Chronic diseases, also known as noncommunicable diseases include conditions like heart disease, cancer, and diabetes that last more than a year and need ongoing medical attention, restrict daily activities, or both. The critical role of controlled-release drug delivery for these illnesses cannot be overstated. It’s particularly important for individuals suffering from long-term illnesses that require extended treatment periods or those who live in regions with restricted resources and healthcare accessibility. Formulations that enable extended medication release are vital for these regions. For example, in September 2022, a report from the Switzerland-based World Health Organization highlighted that every year, 41 million people dying from chronic diseases account for 74 percent of worldwide fatalities. 17 million people succumb before reaching the age of 70, and 77 percent of these deaths occur in low-middle income countries. Predictions suggest these figures will continue to climb, emphasizing how the controlled release drug delivery market’s growth is driven by the increasing prevalence of chronic diseases.
Which Primary Segments of the Controlled Release Drug Delivery Market Are Driving Growth and Industry Transformations?
The controlled release drug delivery market covered in this report is segmented –
1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies
2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,
3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications
4) By End User: Hospitals, Clinics, Personal, Research, Other End Users
Subsegments:
1) By Wurster Technique: Spray Coating, Fluid Bed Coating
2) By Coacervation: Simple Coacervation, Complex Coacervation
3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation
4) By Implants: Biodegradable Implants, Non-Biodegradable Implants
5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems
6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes
7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=9930&type=smp
Which Regions Are Key Players in the Growth of the Controlled Release Drug Delivery Market?
North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Technological Trends Are Reshaping the Controlled Release Drug Delivery Industry Dynamics?
The rapid progression of technology is a predominant trend making headway in the controlled-release drug delivery market. In order to remain competitive, leading businesses in this market are opting for innovative technology. In March 2022, Evonik Industries AG, a pharmaceutical company based in Germany, introduced its latest innovation, UDRATEC SoluFlow – a new microparticle mechanism set to enhance the solubility of active medical ingredients in oral drug compositions. This method of emulsion resolves solubility challenges that cannot be tackled by conventional production procedures. The addition of EUDRATEC SoluFlow to Evonik Health Care’s repertoire of oral drug system solutions, such as oral excipients like EUDRAGIT functional polymers, ready-to-fill functional capsules like EUDRACAP™, and an array of other technologies and services, aims to elevate the efficacy of medications.
View the full report here:
What Parameters Are Used to Define the Controlled Release Drug Delivery Market?
Controlled release drug delivery refers to a dosage form that administers a medicine or medication in a specified way. This drug delivery method continuously delivers pharmaceuticals or medications in predictable kinetics for the predetermined time.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9930
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
